References
- Rabinovitz HS, Barnhill RL. Benign melanocytic neoplasms. In: Dermatology (Bolognia JL, Jorizzo JL, Schaffer JV). 3rded. London: Elsevier Saunders; 2012. p. 1858–59.
- Saha A, Bandyopadhyay D. Nevus of ota. Indian Pediatr. 2014;51:510.
- Zhang Q, Tan C, Jiang P, Yang G. Clinical profile and triggering factors for acquired, bilateral nevus of Ota-like macules. Cutan Ocul Toxicol. 2017;25:1–14.
- Suh DH, Hwang JH, Lee HS, Youn JI, Kim PM. Clinical features of Ota’s naevus in Koreans and its treatment with Q-switched alexandrite laser. Clin Exp Dermatol. 2000;25:269–73.
- Chang CJ, Nelson JS, Achauer BM. Q-Switiched ruby laser of oculodermal melanosis (Nevus of Ota). Plast Reconstr Surg. 1996;98:784–90.
- Tse Y, Levine VJ, Mcclain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched neodymium: yttrium-aluminum-garnetlaser. J Dermatol Surg Oncol. 1994;20:795–800.
- Ota M, Tamino H. A variety of nevus frequently encountered in Japan, nevus usco-caeruleus ophthalmomaxillaris and its relation to pigmentary change in the eye. Tokyo Med J. 1939;63:1242–44.
- Redkar NN, Rawat KJ, Warrier S, Jena A. Nevus of Ota. J Assoc Physicians India. 2016;64:76–88.
- Liu J, Ma YP, Ma XG, Chen JZ, Sun Y, Xu HH, Gao XH, Chen HD, Li YH. A retrospective study of q-switched alexandrite laser in treating nevus of Ota. Dermatol Surg. 2011;37:1480–85.
- Seo HM, Choi CW, Kim WS. Beneficial effects of early treatment of nevus of Ota with low-fluence 1,064-nm Q-switched Nd: YAGlaser. Dermatol Surg. 2015;41:142–48.
- Choi JE, Lee JB, Park KB, Kim BS, Yeo UC, Huh CH, Kim JH, Kye YC. A retrospective analysis of the clinical efficacies of Q-switched Alexandrite and Q-switched Nd: YAGlasers in the treatment of nevus of Ota in Korean patients. J Dermatol Treat. 2015;26:240–45.
- Shah VV, Bray FN, Aldahan AS, Mlacker S, Nouri K. Lasers and nevus of Ota: a comprehensive review. Lasers Med Sci. 2016;31:179–85.
- Lowe NJ, Wieder JM, Sawcer D, Burrows P, Chalet M. Nevus of Ota: treatment with high energy fluences of the Qswitche ruby laser. J Am Acad Dermatol. 1993;29:997–1001.
- Yu P, Yu N, Diao W, Yang X, Feng Y, Qi Z. Comparison of clinical efficacy and complications between Q-switched alexandrite laser and Q-switched Nd: YAGlaser on nevus of Ota: a systematic review and meta-analysis. Lasers Med Sci. 2016;31:581–91.
- Sami L, Changzheng H, Yan L. Factors affecting response, number of laser sessions and complications in nevus of Ota treated by Q-switched alexandrite laser: a retrospective study. G Ital Dermatol Venereol. 2016;151:160–68.
- Lee HS, Kim M, Kang HY. Recurrence of nevus of Ota after successful laser treatment: possible role of dermal stemcells. Ann Dermatol. 2016;28:647–49.
- Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, Lee JT, Herlyn M. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci. 2010;123:853–60.
- Zabierowski SE, Fukunaga-Kalabis M, Li L, Herlyn M. Dermisderived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res. 2011;24:422–29.
- Kono T, Nozaki M, Chan HH, Mikashima Y. A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus ofOta. Lasers Surg Med. 2001;29:156–59.